U.S. Food and Drug Administration
Protecting and Promoting Your Health
Small Business Assistance
Center for Drug Evaluation and Research
Engaging with the FDA During New Drug Development
Formal Meetings with FDA
|
Question: Is the meeting held to discuss the overall development program for products granted "Breakthrough Therapy" designation status a new Type B meeting?
|
|
Answer:
Yes. |
USER INSTRUCTIONS:
Click NEXT to continue.
Page 16 of 38